Overview

Treatment of Women After Severe Postpartum Haemorrhage

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to get explorative information about IV high single dose infusion of iron isomaltoside 1000 compared to RBC transfusion in the treatment of severe PP-IDA evaluated as physical fatigue
Phase:
Phase 3
Details
Lead Sponsor:
Pharmacosmos A/S
Collaborator:
BioStata
Treatments:
Ferric Compounds
Iron
Iron isomaltoside 1000